Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SHUBIN, H.
Right arrow Articles by SINGHAPHAKDI, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SHUBIN, H.
Right arrow Articles by SINGHAPHAKDI, S.
(Chest. 1958;34:138-149.)
© 1958 American College of Chest Physicians

The Place of Steroids in Pulmonary Disease

HARRY SHUBIN M.D., F.C.C.P.1; ROBERT LAMBERT M.D., F.C.C.P.1; CHARLES A. HEIKEN M.D., F.C.C.P.1; and SAN SINGHAPHAKDI M.D.1

1 Philadelphia General Hospital, Northern Division, and Rush Hospital.

This presentation attempted to determine the place of steroids in pulmonary diseases, especially tuberculosis. The beneficial effects of various steroids in rheumatoid arthritis, asthma, collagen diseases, etc., are well known. However, we reported 38 patients, who had reactivation of latent or inactive tuberculosis following such therapy. The physician must investigate the presence of tuberculosis, by skin test and x-ray films, and when in doubt, simultaneously administer anti-tuberculosis drugs. Only by using these drugs judiciously, that is, the minimum dosage for the shortest period necessary to obtain the desired effects, are complications diminished.

Paradoxically, the value of steroids in the treatment of tuberculosis has been established. From its life-saving action in 33 acute, toxic, miliary, meningeal, etc., to its stimulation effect in 60 chronic patients, either prolonging their lives, or hastening desensitization thus allowing more effective therapy. All of these patients received effective anti-tuberculosis chemotherapy during this study.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1958 by the American College of Chest Physicians.